The vast majority of studies to determine the biological activity of r
ecombinant human thyrotropin (rhTSH) have been carried out in the mous
e. We have recently reported that 0.1 mg of rhTSH IM (one-ninth the do
se given in thyroid cancer patients) given to normal subjects elicits
a brisk rise in serum thyroxine (T-4), triiodothyronine (T-3), and thy
roglobulin (Tg) concentrations. In contrast, in initial studies in the
rat, a low dose of rhTSH failed to increase serum T-4 or T-3 concentr
ations. The present study was, therefore, carried out to determine the
biological activity of rhTSH in euthyroid and in T-3-treated, TSH-sup
pressed rats and mice. Doses of rhTSH based on body weight were used a
nd resulted in similar serum human thyrotropin (hTSH) concentrations i
n the two species. Euthyroid and TSH-suppressed mice responded briskly
to rhTSH administration. In contrast, serum T-4 did not increase afte
r rhTSH administration in euthyroid rats. In TSH-suppressed rats, the
increase in serum T-4 was similar to that observed in TSH suppressed m
ice. These observations suggest that rhTSH more readily displaces endo
genous TSH from the mouse than from the rat thyroid TSH receptor, beca
use equal responses were observed when endogenous TSH was suppressed.